231 lines
16 KiB
JSON
231 lines
16 KiB
JSON
{
|
|
"date": "2026-04-14",
|
|
"llm_provider": "google",
|
|
"recommendations": [
|
|
{
|
|
"ticker": "ALB",
|
|
"rank": 1,
|
|
"company_name": "Albemarle Corporation",
|
|
"description": "Albemarle Corporation is a specialty chemicals manufacturing company highly focused on lithium and bromine.",
|
|
"strategy_match": "minervini",
|
|
"pipeline": "minervini",
|
|
"final_score": 92,
|
|
"confidence": 9,
|
|
"risk_level": "moderate",
|
|
"reason": "(1) Albemarle boasts a perfect Minervini RS Rating of 100/100, consolidating within 4% of its 52-week high with a 261% gain off its lows. (2) The timing is urgent as a recent MACD bullish crossover (histogram at 0.508) and rising OBV (151.4M) suggest an imminent breakout from this high-tight flag structure. (3) The risk/reward is favorable as it trades above its 50-day SMA of $170.91, providing a clear support level for a tight stop. (4) The primary risk is a potential rejection at resistance or macro volatility, especially given the high ATR of 5.1% ($9.46) which could trigger premature stop-outs.",
|
|
"entry_price": null,
|
|
"discovery_date": "2026-04-14",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "AMAT",
|
|
"rank": 2,
|
|
"company_name": "Applied Materials, Inc.",
|
|
"description": "Applied Materials is a global leader in materials engineering solutions for the semiconductor and display industries.",
|
|
"strategy_match": "minervini",
|
|
"pipeline": "minervini",
|
|
"final_score": 89,
|
|
"confidence": 9,
|
|
"risk_level": "moderate",
|
|
"reason": "(1) Applied Materials exhibits a textbook Minervini Stage 2 setup with an RS Rating of 96/100 and price action within 1% of its 52-week high. (2) The immediate catalyst is the tech sector rebound coupled with a fresh MACD bullish crossover (histogram strengthening to 5.459) and rising volume (OBV at 223.7M). (3) The setup offers asymmetric upside, supported heavily by the 20-period EMA at $364.66 and strong institutional buying (price 10.3% above VWAP). (4) The primary risk is market-wide tech weakness or a false breakout at 52-week highs, making a strict stop below the 20 EMA prudent.",
|
|
"entry_price": null,
|
|
"discovery_date": "2026-04-14",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "COE",
|
|
"rank": 3,
|
|
"company_name": "China Online Education Group",
|
|
"description": "China Online Education Group provides online English language education services to students in China.",
|
|
"strategy_match": "insider_buying",
|
|
"pipeline": "insider_buying",
|
|
"final_score": 85,
|
|
"confidence": 8,
|
|
"risk_level": "speculative",
|
|
"reason": "(1) COE features an exceptionally large insider cluster buy, highlighted by the CEO's massive $35.3 million stock purchase. (2) Action is urgent because the technicals have just aligned with this insider conviction, printing a MACD bullish crossover (histogram at 0.532) and rising RSI of 53.2. (3) The risk/reward profile is highly attractive as the stock is heavily oversold relative to its 200 SMA, leaving significant upside runway for reversion. (4) A key risk is that the stock remains in a longer-term downtrend (price is 5.9% below its 50 SMA), and failure to reclaim this level could result in further downside.",
|
|
"entry_price": null,
|
|
"discovery_date": "2026-04-14",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "ACHC",
|
|
"rank": 4,
|
|
"company_name": "Acadia Healthcare Company, Inc.",
|
|
"description": "Acadia Healthcare Company is a leading provider of behavioral healthcare services across the United States.",
|
|
"strategy_match": "short_squeeze",
|
|
"pipeline": "short_squeeze",
|
|
"final_score": 85,
|
|
"confidence": 8,
|
|
"risk_level": "high",
|
|
"reason": "(1) ACHC is a prime short squeeze candidate with a massive 42.1% short interest and 6.5 days to cover, setting the stage for a rapid short covering rally. (2) Squeeze pressure is mounting immediately as the stock just printed a Golden Cross and a MACD bullish crossover, with OBV rising to 75.2M. (3) The trade offers a high-reward dynamic, supported by a 50-day SMA at $20.98 that is well below current levels, acting as a structural floor. (4) The main risk is the upcoming earnings in 15 days, which introduces binary risk that could either ignite the squeeze or crush the momentum.",
|
|
"entry_price": null,
|
|
"discovery_date": "2026-04-14",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "RKLB",
|
|
"rank": 5,
|
|
"company_name": "Rocket Lab USA, Inc.",
|
|
"description": "Rocket Lab USA provides launch services and space systems solutions for the space industry.",
|
|
"strategy_match": "social_dd",
|
|
"pipeline": "social_dd",
|
|
"final_score": 83,
|
|
"confidence": 8,
|
|
"risk_level": "high",
|
|
"reason": "(1) Rocket Lab combines exceptional social sentiment (75/100 score) with a fundamental catalyst as the CEO cancels stock plans and the company unveils the 'Gauss' thruster system. (2) The timing is urgent because the stock is experiencing explosive accumulation, with OBV surging to 781.0M and a MACD bullish crossover (histogram at 0.647) confirming the momentum. (3) The risk/reward is skewed highly to the upside given the confluence of news and a strong uptrend above the 50-day SMA of $70.00. (4) The primary risk is the high volatility (ATR of 7.7%), meaning broader market selling could easily trigger a 1.5x ATR stop-loss around $62.43.",
|
|
"entry_price": null,
|
|
"discovery_date": "2026-04-14",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "BLK",
|
|
"rank": 6,
|
|
"company_name": "BlackRock, Inc.",
|
|
"description": "BlackRock is the world's largest asset manager, providing investment management, risk management, and advisory services.",
|
|
"strategy_match": "earnings_play",
|
|
"pipeline": "earnings_play",
|
|
"final_score": 81,
|
|
"confidence": 8,
|
|
"risk_level": "low",
|
|
"reason": "(1) BlackRock provides a strong earnings play, having just reported a 27% YoY revenue increase and record AUM of $13.9 trillion. (2) The timing is optimal as the post-earnings reaction triggered a sharp MACD bullish crossover (histogram at 10.698) alongside rising on-balance volume. (3) The risk/reward profile is compelling for a momentum continuation trade, with the stock trading comfortably above its 50-day SMA of $1015.24. (4) The main risk is an overextended move as the stock nears the upper Bollinger Band, which could lead to mean reversion if broader financial sector sentiment weakens.",
|
|
"entry_price": null,
|
|
"discovery_date": "2026-04-14",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "AMT",
|
|
"rank": 7,
|
|
"company_name": "American Tower Corporation",
|
|
"description": "American Tower Corporation is a leading independent owner, operator, and developer of multitenant communications real estate.",
|
|
"strategy_match": "options_flow",
|
|
"pipeline": "options_flow",
|
|
"final_score": 79,
|
|
"confidence": 7,
|
|
"risk_level": "low",
|
|
"reason": "(1) American Tower is signaling institutional accumulation through unusual options flow featuring 2 bullish calls and 0 puts. (2) The timing for entry is precise as the stock just formed a MACD bullish crossover (histogram at 1.171) and trades 2.9% above VWAP. (3) The risk/reward is favorable with the stock in a steady uptrend, anchored by support at the 50-day SMA of $180.68. (4) A key risk is REIT sector sensitivity to interest rate expectations, which could invalidate the technical breakout if yields unexpectedly spike.",
|
|
"entry_price": null,
|
|
"discovery_date": "2026-04-14",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "JPM",
|
|
"rank": 8,
|
|
"company_name": "JPMorgan Chase & Co.",
|
|
"description": "JPMorgan Chase is a leading global financial services firm and one of the largest banking institutions in the United States.",
|
|
"strategy_match": "earnings_play",
|
|
"pipeline": "earnings_play",
|
|
"final_score": 78,
|
|
"confidence": 7,
|
|
"risk_level": "low",
|
|
"reason": "(1) JPMorgan is a premium post-earnings momentum play after beating expectations with a $16.5 billion profit and positive CEO commentary. (2) Momentum is accelerating right now, evidenced by a strong MACD bullish crossover (histogram strengthening to 3.325) and OBV rising to 138.5M. (3) The setup presents an attractive risk/reward profile as institutional buying keeps the price 7.4% above VWAP with a moderate ATR of 2.2%. (4) The key risk is that the stock is bumping against its upper Bollinger Band at $313.03, which may prompt short-term profit-taking.",
|
|
"entry_price": null,
|
|
"discovery_date": "2026-04-14",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "AMD",
|
|
"rank": 9,
|
|
"company_name": "Advanced Micro Devices, Inc.",
|
|
"description": "Advanced Micro Devices is a global semiconductor company that develops computer processors and related technologies for business and consumer markets.",
|
|
"strategy_match": "minervini",
|
|
"pipeline": "minervini",
|
|
"final_score": 77,
|
|
"confidence": 7,
|
|
"risk_level": "moderate",
|
|
"reason": "(1) AMD demonstrates elite Minervini characteristics with an RS Rating of 92/100 and price consolidating just 6% off its 52-week high. (2) The trade demands attention now due to a fresh MACD bullish crossover (histogram at 4.807) and strong OBV accumulation of 1.2 billion. (3) Risk/reward remains highly asymmetric in the direction of the underlying trend, with price well above its 50-day SMA of $209.24. (4) The primary risk is its overbought status (RSI at 70.8, Stochastic at 90.5) and proximity to the upper Bollinger Band, increasing the probability of a short-term pullback.",
|
|
"entry_price": null,
|
|
"discovery_date": "2026-04-14",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "HYMC",
|
|
"rank": 10,
|
|
"company_name": "Hycroft Mining Holding Corporation",
|
|
"description": "Hycroft Mining Holding Corporation operates as a gold and silver development company.",
|
|
"strategy_match": "insider_buying",
|
|
"pipeline": "insider_buying",
|
|
"final_score": 75,
|
|
"confidence": 7,
|
|
"risk_level": "high",
|
|
"reason": "(1) Hycroft Mining is bolstered by significant insider buying, specifically a $7.7 million purchase by a 10% owner, aligning with record gold prices. (2) The technical timing is ripe as the stock recently posted a MACD bullish crossover (histogram at 0.791) and OBV has risen to 109.7M. (3) The risk/reward is speculative but highly explosive, trading in a strong uptrend above its 50-day SMA of $38.79. (4) High volatility (ATR of 10.3%) is the major risk, making position sizing critical to avoid being shaken out by normal daily fluctuations.",
|
|
"entry_price": null,
|
|
"discovery_date": "2026-04-14",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "CSCO",
|
|
"rank": 11,
|
|
"company_name": "Cisco Systems, Inc.",
|
|
"description": "Cisco Systems designs, manufactures, and sells networking hardware, software, and telecommunications equipment.",
|
|
"strategy_match": "options_flow",
|
|
"pipeline": "options_flow",
|
|
"final_score": 74,
|
|
"confidence": 7,
|
|
"risk_level": "low",
|
|
"reason": "(1) Cisco shows hidden bullish intent through an unusual options flow consisting of 2 bullish calls and 0 puts against a backdrop of steady accumulation. (2) The setup is timely as the price rides a strong uptrend and maintains positive momentum above the 20-period EMA of $80.20. (3) It offers a low-risk profile with a modest ATR of 2.6% ($2.13) and solid structural support at the 50-day SMA of $79.47. (4) The primary risk is a weakening ADX of 13.9, which signals a lack of strong directional trend and could result in range-bound chop rather than a breakout.",
|
|
"entry_price": null,
|
|
"discovery_date": "2026-04-14",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "MDAI",
|
|
"rank": 12,
|
|
"company_name": "Spectral AI, Inc.",
|
|
"description": "Spectral AI is a predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions.",
|
|
"strategy_match": "social_dd",
|
|
"pipeline": "social_dd",
|
|
"final_score": 72,
|
|
"confidence": 6,
|
|
"risk_level": "speculative",
|
|
"reason": "(1) MDAI provides a compelling social catalyst setup with a 75/100 Reddit score centered around an upcoming FDA De Novo catalyst and their new DeepView System. (2) Action is urgent as the technicals confirm the hype with a MACD bullish crossover and the price pushing 17.2% above its 20-period EMA. (3) The risk/reward is highly skewed for a speculative play, supported by institutional buying pushing the price 28.7% above VWAP. (4) The main risk is the extreme volatility (ATR of 6.9%) and the fact that it is a micro-cap FDA play, meaning any delay in the catalyst could trigger an immediate gap down.",
|
|
"entry_price": null,
|
|
"discovery_date": "2026-04-14",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "TER",
|
|
"rank": 13,
|
|
"company_name": "Teradyne, Inc.",
|
|
"description": "Teradyne is a leading supplier of automatic test equipment used to test semiconductors, wireless products, and electronic systems.",
|
|
"strategy_match": "analyst_upgrade",
|
|
"pipeline": "analyst_upgrade",
|
|
"final_score": 71,
|
|
"confidence": 6,
|
|
"risk_level": "moderate",
|
|
"reason": "(1) Teradyne benefits from a fresh analyst upgrade by Patton Fund Management and alignment with a broader tech sector AI relief rally. (2) The timing is excellent due to a massive MACD bullish crossover (histogram at 7.326) and a 15.49% 5-day surge confirming strong momentum. (3) The risk/reward profile is strong for trend-followers, with the stock positioned 16.8% above VWAP indicating relentless institutional bidding. (4) The key risk is technical overextension; with an RSI of 69.4 and price at the upper Bollinger Band, the stock is vulnerable to mean reversion.",
|
|
"entry_price": null,
|
|
"discovery_date": "2026-04-14",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "ANAB",
|
|
"rank": 14,
|
|
"company_name": "AnaptysBio, Inc.",
|
|
"description": "AnaptysBio is a clinical-stage biopharmaceutical company developing immunology therapeutics.",
|
|
"strategy_match": "short_squeeze",
|
|
"pipeline": "short_squeeze",
|
|
"final_score": 70,
|
|
"confidence": 6,
|
|
"risk_level": "high",
|
|
"reason": "(1) AnaptysBio offers extreme short squeeze potential with short interest at 30.6% of the float and 9.8 days to cover. (2) The squeeze is primed to trigger immediately as technical momentum accelerates, shown by a MACD bullish crossover and an expanding ADX of 35.7. (3) Risk/reward is compelling as the stock is in a strong uptrend, 18.1% above its 50-day SMA of $58.18, providing a wide buffer against trend changes. (4) The primary risk is the high ATR of 6.0%, meaning a failed breakout attempt could lead to a rapid and punishing reversal before a stop can be cleanly executed.",
|
|
"entry_price": null,
|
|
"discovery_date": "2026-04-14",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "APH",
|
|
"rank": 15,
|
|
"company_name": "Amphenol Corporation",
|
|
"description": "Amphenol is one of the world's largest designers, manufacturers, and marketers of electrical, electronic, and fiber optic connectors.",
|
|
"strategy_match": "minervini",
|
|
"pipeline": "minervini",
|
|
"final_score": 68,
|
|
"confidence": 6,
|
|
"risk_level": "moderate",
|
|
"reason": "(1) Amphenol displays strong Minervini Stage 2 characteristics with an RS Rating of 90/100 and price just 11% below its 52-week high. (2) The immediate entry is justified by a MACD bullish crossover (histogram at 2.541) and rising OBV of 252.7M. (3) The trade presents a favorable risk/reward structure, well-supported by the 50-day SMA at $136.66 and a manageable ATR of 4.1%. (4) A potential risk is the weakening ADX (14.4), suggesting the trend may lose momentum and consolidate before it can successfully challenge the recent highs.",
|
|
"entry_price": null,
|
|
"discovery_date": "2026-04-14",
|
|
"status": "open"
|
|
}
|
|
]
|
|
} |